Form 4: Theravance Biopharma Insider Reports Stock Transaction
Insider Transaction (Form 4)
Weiss Asset Management LP and 2 others reported changes in beneficial ownership of Theravance Biopharma, Inc. common stock on September 23, 2026.
Summary
- Other acquisition/disposition: disposed of 7,457,060 Ordinary Share $0.00001 Par Value at $17.00 ($126,770,020) on September 23, 2026 (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Weiss Asset Management LP — Other (Former 10% Owner)
Andrew M Weiss — Other (Former 10% Owner)
Wam Gp Llc — Other (Former 10% Owner)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-23 | Other acquisition/disposition | Ordinary Share $0.00001 Par Value | 7,457,060 | $17 | $126.8M | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-23 | Other acquisition/disposition (7,457,060 shares) |
Keywords
insider transaction, Form 4, TBPH, Theravance Biopharma, Inc., neutral, Weiss Asset Management LP, Andrew M Weiss, Wam Gp Llc
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.